<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="jh" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">jh</book-part-id>
      <title-group>
        <title>Juvenile Hereditary Hemochromatosis</title>
        <alt-title alt-title-type="alt-title">Synonym: Hemochromatosis, Type 2</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goldberg</surname>
            <given-names>Y Paul</given-names>
          </name>
          <degrees>MB ChB, PhD, FRCPC</degrees>
          <aff>Vice President, Clinical Development<break/>Xenon Pharmaceuticals Inc<break/>Burnaby, British Columbia, Canada</aff>
          <email>pgoldberg@xenon-pharma.com</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>17</day>
          <month>2</month>
          <year>2005</year>
        </date>
        <date date-type="updated">
          <day>11</day>
          <month>8</month>
          <year>2011</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="ebj" document-type="chapter">Junctional Epidermolysis Bullosa</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="jps" document-type="chapter">Juvenile Polyposis Syndrome</related-object>
      <abstract id="jh.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Juvenile hemochromatosis is characterized by onset of severe iron overload occurring typically in the first to third decades of life. Males and females are equally affected. Prominent clinical features include hypogonadotropic hypogonadism, cardiomyopathy, arthropathy, and liver fibrosis or cirrhosis. Hepatocellular cancer has not been reported. The main cause of death is cardiac disease. If juvenile hemochromatosis is detected early enough and if blood is removed regularly through the process of phlebotomy to achieve iron depletion, morbidity and mortality are greatly reduced.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Serum ferritin concentration ranges from 1000 to 7000 &#x000b5;g/L. Transferrin-iron saturation is typically very high, often reaching 100%. MRI is used as a noninvasive method of quantifying hepatic iron overload. A hepatic iron index of higher than 1.9 on liver biopsy suggests iron overload. The two genes in which pathogenic variants are known to cause juvenile hemochromatosis are <italic toggle="yes">HJV</italic> (<italic toggle="yes">HFE2</italic>) (locus name HFE2A) encoding hemojuvelin, accounting for more than 90% of cases, and <italic toggle="yes">HAMP</italic> (<italic toggle="yes">HEPC</italic>) (locus name HFE2B) encoding hepcidin, accounting for fewer than 10% of cases.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Phlebotomy for treatment of iron overload is the same as for classic HFE-associated hemochromatosis, i.e., phlebotomy of one unit of blood (~200 mg of iron) one to two times per week for up to two to three years to reduce iron stores to desired levels (serum ferritin concentration below 50 ng/mL and normal transferrin-iron saturation), followed by phlebotomies to maintain normal serum iron studies. Conventional treatment of secondary complications, including hypogonadotropic hypogonadism, arthropathy, cardiac failure, liver disease, diabetes mellitus.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Regular phlebotomies until excess iron stores are depleted.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Hormone replacement therapy (HRT) to prevent osteoporosis.</p>
          <p><italic toggle="yes">Surveillance:</italic> Monitor those at risk with annual measurement of serum ferritin concentration and transferrin-iron saturation starting in early childhood. For those with hepatic cirrhosis, monitor for hepatocellular cancer with biannual abdominal ultrasound examination and serum alpha-fetoprotein concentration.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Alcohol consumption; ingestion of iron-containing preparations and supplemental vitamin C; handling or eating uncooked shellfish or marine fish because of risk of fatal septicemia from the marine bacterium <italic toggle="yes">V vulnificus</italic>.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Biochemical testing (i.e., serum ferritin concentration and transferrin-iron saturation) or molecular genetic testing in relatives at risk before evidence of organ damage from iron overload; monitor sibs with annual measurement of serum ferritin concentration and transferrin-iron saturation starting in early childhood.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Juvenile hemochromatosis is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an unaffected carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing are possible if both pathogenic variants have been identified in the family; however, requests for prenatal testing for conditions which (like juvenile hereditary hemochromatosis) do not affect intellect and have effective treatment available are not common.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="jh.Diagnosis">
        <title>Diagnosis</title>
        <sec id="jh.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Juvenile hemochromatosis (JHH) should be suspected in any child, adolescent, or young adult with findings of iron overload; such findings include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Hypogonadotropic hypogonadism</p>
            </list-item>
            <list-item>
              <p>Hepatomegaly</p>
            </list-item>
            <list-item>
              <p>Hepatic cirrhosis</p>
            </list-item>
            <list-item>
              <p>Hepatocellular carcinoma</p>
            </list-item>
            <list-item>
              <p>Diabetes mellitus</p>
            </list-item>
            <list-item>
              <p>Cardiomyopathy</p>
            </list-item>
            <list-item>
              <p>Arrhythmias</p>
            </list-item>
            <list-item>
              <p>Arthritis</p>
            </list-item>
            <list-item>
              <p>Progressive increase in skin pigmentation</p>
            </list-item>
          </list>
          <p>Many of these features are evident before age 30 years.</p>
          <p>Presenting symptoms in the first or second decade may be less specific; they include lack of appetite, fatigue, amenorrhea, or arthralgia.</p>
        </sec>
        <sec id="jh.Testing">
          <title>Testing</title>
          <p><bold>Biochemical testing.</bold> Data are limited as documented cases of juvenile hemochromatosis are rare; however, the following two biochemical measurements should be performed:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Serum ferritin concentration</bold>, which ranges from 1000 to 7000 &#x000b5;g/L in affected individuals (normal: 20-260 &#x000b5;g/L for male children/adolescents; 5-140 &#x000b5;g/L for female children/adolescents, 25-300 &#x000b5;g/L for adult males, and 25-200 &#x000b5;g/L for adult females)</p>
            </list-item>
            <list-item>
              <p><bold>Transferrin-iron saturation</bold>, which is typically very high, often reaching 100% (normal: 15%-50% in children/adolescents; ~ 33% in adults)</p>
            </list-item>
          </list>
          <p>
            <bold>Imaging</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Magnetic resonance imaging (MRI)</bold> has become a valuable noninvasive technique to quantify hepatic iron overload [<xref ref-type="bibr" rid="jh.REF.gandon.2004.357">Gandon et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Superconducting quantum interference device (SQUID)</bold> is a noninvasive method for quantifying liver iron biomagnetometry [<xref ref-type="bibr" rid="jh.REF.fung.2004.5">Fung et al 2004</xref>].</p>
            </list-item>
          </list>
          <p><bold>Liver biopsy.</bold> A hepatic iron index of higher than 1.9 suggests iron overload in <related-object link-type="booklink" source-id="gene" document-id="hemochromatosis" document-type="chapter"><italic toggle="yes">HFE</italic>-associated hereditary hemochromatosis</related-object>. Similarly, because iron overload is more severe in juvenile hemochromatosis, an index of higher than 1.9 also applies for juvenile hemochromatosis (normal: &#x0003c;1.0) [<xref ref-type="bibr" rid="jh.REF.pietrangelo.2004.2383">Pietrangelo 2004</xref>].</p>
          <sec id="jh.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Genes.</bold> Mutation of two genes is currently known to cause juvenile hemochromatosis:</p>
            <list list-type="bullet">
              <list-item>
                <p><italic toggle="yes">HJV</italic> (<italic toggle="yes">HFE2</italic>) (locus name HJV [HFE2A]) encoding hemojuvelin, accounts for more than 90% of cases reported to date.</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">HAMP (HEPC)</italic> (locus name HFE2B) encoding hepcidin, accounts for fewer than 10% of cases reported to date.</p>
              </list-item>
            </list>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <p>
              <bold>
                <italic toggle="yes">HJV</italic>
              </bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Sequence analysis or scanning for pathogenic variants</bold> detects pathogenic variants in more than 98% of individuals with <italic toggle="yes">HJV</italic>-related juvenile hemochromatosis. Neither sequence analysis nor scanning for pathogenic variants detects exon or whole-gene deletions.</p>
              </list-item>
              <list-item>
                <p><bold>Targeted analysis for</bold>
<bold>pathogenic variants.</bold> To date, the most frequently reported pathogenic variant in <italic toggle="yes">HJV</italic> is p.Gly320Val; it accounted for two thirds of pathogenic variants identified in the original <italic toggle="yes">HJV</italic> positional cloning report [<xref ref-type="bibr" rid="jh.REF.papanikolaou.2004.77">Papanikolaou et al 2004</xref>]. The p.Gly320Val pathogenic variant was identified in all French-Canadian individuals with juvenile hemochromatosis phenotypes from the Saguenay-Lac-Saint-Jean region [<xref ref-type="bibr" rid="jh.REF.lanzara.2004.4317">Lanzara et al 2004</xref>].</p>
              </list-item>
            </list>
            <p>
              <bold>
                <italic toggle="yes">HAMP</italic>
              </bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Sequence analysis or scanning</bold>
<bold>for</bold>
<bold>pathogenic variants</bold> detects pathogenic variants in more than 98% of individuals with <italic toggle="yes">HAMP</italic>-related juvenile hemochromatosis. Neither sequence analysis nor scanning for pathogenic variants detects exon or whole-gene deletions.</p>
              </list-item>
            </list>
            <table-wrap id="jh.T.summary_of_molecular_genetic_testin" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Juvenile Hereditary Hemochromatosis (JHH)</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of JHH Caused by Mutation of This Gene</th>
                    <th id="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency&#x000a0;<sup>3</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">HJV</italic>
                    </td>
                    <td headers="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">&#x0003e;90%</td>
                    <td headers="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for pathogenic variants</td>
                    <td headers="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Gly320Val</td>
                    <td headers="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">See footnote 4</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>5</sup> / scanning for pathogenic variants&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;98%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">HAMP</italic>
                    </td>
                    <td headers="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;10%</td>
                    <td headers="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup> / scanning for pathogenic variants&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_jh.T.summary_of_molecular_genetic_testin_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;98%</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="jh.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="jh" object-id="jh.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="jh.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="jh.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="jh.TF.1.3">
                  <label>3. </label>
                  <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
                </fn>
                <fn id="jh.TF.1.4">
                  <label>4. </label>
                  <p>Most frequently reported pathogenic variant [<xref ref-type="bibr" rid="jh.REF.papanikolaou.2004.77">Papanikolaou et al 2004</xref>]; identified in all affected French-Canadian individuals from the Saguenay-Lac-Saint-Jean region [<xref ref-type="bibr" rid="jh.REF.lanzara.2004.4317">Lanzara et al 2004</xref>]</p>
                </fn>
                <fn id="jh.TF.1.5">
                  <label>5. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="jh.TF.1.6">
                  <label>6. </label>
                  <p>Sequence analysis and scanning of the entire gene for pathogenic variants can have similar detection frequencies; however, detection rates for scanning may vary considerably among laboratories depending on the specific protocol used.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="jh.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To establish the diagnosis of juvenile hemochromatosis in a proband</bold>, the following tests are used:</p>
          <list list-type="bullet">
            <list-item>
              <p>Biochemical testing (high serum ferritin concentration; high transferrin-iron saturation)</p>
            </list-item>
            <list-item>
              <p>Molecular testing of <italic toggle="yes">HJV</italic> and <italic toggle="yes">HAMP</italic></p>
              <list list-type="bullet">
                <list-item>
                  <p>Perform targeted analysis for the p.Gly320Val allele in <italic toggle="yes">HJV</italic>, if no or only one p.Gly320Val allele is identified, continue with sequence analysis / scanning of the entire coding region for pathogenic variants; OR</p>
                </list-item>
                <list-item>
                  <p>Perform sequence analysis / scanning of the entire coding region for pathogenic variants; if neither or only one pathogenic variant in <italic toggle="yes">HJV</italic> is identified, perform sequence analysis / scanning of <italic toggle="yes">HAMP</italic> for pathogenic variants.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If homozygous or compound heterozygous pathogenic variants are not identified in either <italic toggle="yes">HJV</italic> or <italic toggle="yes">HAMP</italic>, consider testing for <related-object link-type="booklink" source-id="gene" document-id="hemochromatosis" document-type="chapter"><italic toggle="yes">HFE</italic>-associated hemochromatosis</related-object>. However, the clinical relevance of identifying one pathogenic variant in <italic toggle="yes">HJV</italic> or <italic toggle="yes">HAMP</italic> and <italic toggle="yes">HFE</italic> or two pathogenic variants in <italic toggle="yes">HFE</italic> and one in one of the other two genes is unknown. (See <xref ref-type="sec" rid="jh.Differential_Diagnosis">Differential Diagnosis</xref>.)</p>
            </list-item>
            <list-item>
              <p>Hepatic imaging</p>
            </list-item>
            <list-item>
              <p>Possible liver biopsy</p>
              <p>Note: Liver biopsy is usually used for prognostication (see <xref ref-type="sec" rid="jh.Evaluations_Following_Initial_Diagnos">Management</xref>); however, it may be used infrequently for diagnosis. Guidelines for biopsy are not defined for JHH.</p>
            </list-item>
          </list>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the pathogenic variants in the family.</p>
          <p>Note: Carriers are heterozygotes for an autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variants in the family.</p>
        </sec>
      </sec>
      <sec id="jh.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="jh.Clinical_Description">
          <title>Clinical Description</title>
          <p>Juvenile hemochromatosis (JHH) is characterized by early onset of severe iron overload. Juvenile hemochromatosis typically presents in the first to third decade of life; however, the adult presentation of three individuals with <italic toggle="yes">HJV</italic> pathogenic variants [<xref ref-type="bibr" rid="jh.REF.koyama.2005.740">Koyama et al 2005</xref>] highlights the wide spectrum of disease phenotypes related to <italic toggle="yes">HJV</italic> pathogenic variants: from classic JHH at one extreme to late onset adult form at the other extreme.</p>
          <p>Males and females are equally affected.</p>
          <p>In clinical practice, individuals with juvenile hemochromatosis are rarely diagnosed before significant iron overload occurs.</p>
          <p>Prominent clinical features include hypogonadotropic hypogonadism, cardiomyopathy, arthropathy, and liver fibrosis or cirrhosis. Osteopenia and osteoporosis are common complications in individuals with prolonged hypogonadism [<xref ref-type="bibr" rid="jh.REF.vaiopoulos.2003.227">Vaiopoulos et al 2003</xref>]. The clinical course is severe, with the main cause of death being cardiac-related disease [<xref ref-type="bibr" rid="jh.REF.de_gobbi.2002.973">De Gobbi et al 2002</xref>]. The prevalence of cardiac disease is strikingly high and in some instances is the presenting finding [<xref ref-type="bibr" rid="jh.REF.filali.2004.120">Filali et al 2004</xref>].</p>
          <p>Although individuals with juvenile hemochromatosis may develop adrenocortical insufficiency or hypothyroidism, these complications are rare [<xref ref-type="bibr" rid="jh.REF.varkonyi.2000.252">Varkonyi et al 2000</xref>]. While diabetes is common in individuals with <italic toggle="yes">HFE</italic>-related hemochromatosis, the extent of glucose impairment in people with JHH has not been well defined. However, in one study of 26 patients from 20 families with JHH, reduced glucose tolerance was identified in 58% [<xref ref-type="bibr" rid="jh.REF.de_gobbi.2002.973">De Gobbi et al 2002</xref>].</p>
          <p>Despite the more severe iron overload seen in juvenile hemochromatosis (as compared to <italic toggle="yes">HFE</italic>-associated hereditary hemochromatosis), hepatocellular cancer has not been reported in juvenile hemochromatosis [<xref ref-type="bibr" rid="jh.REF.camaschella.2002.242">Camaschella et al 2002</xref>]; a possible explanation is that untreated individuals with juvenile hemochromatosis die prematurely as a result of cardiac complications [<xref ref-type="bibr" rid="jh.REF.camaschella.1998.227">Camaschella 1998</xref>].</p>
          <p>If juvenile hemochromatosis is detected early enough and blood is removed regularly through the process of phlebotomy to achieve iron depletion, morbidity and mortality are greatly reduced.</p>
        </sec>
        <sec id="jh.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No genotype-phenotype correlations have been reported with <italic toggle="yes">HJV</italic>-related juvenile hemochromatosis or <italic toggle="yes">HAMP</italic>-related juvenile hemochromatosis; the clinical and biochemical phenotypes reported for all pathogenic variants identified so far appear similar.</p>
          <p><xref ref-type="bibr" rid="jh.REF.koyama.2005.740">Koyama et al [2005]</xref> reported three Japanese individuals (two from the same family) presenting around age 50 years with typical clinical signs of JHH and hepatic histologic damage compatible with hemochromatosis. All three were homozygous for an <italic toggle="yes">HJV</italic> pathogenic variant.</p>
          <list list-type="bullet">
            <list-item>
              <p>One was homozygous for the novel pathogenic missense variant 745G&#x0003e;C (p.Asp249His), suggesting that the variant, which results in a relatively mild late-onset phenotype, may not be highly detrimental to hemojuvelin functioning.</p>
            </list-item>
            <list-item>
              <p>The two from the same family were homozygous for another novel pathogenic variant, 934C&#x0003e;T (p.Gln312Ter), which induced a premature stop codon, suggesting that unidentified factor(s) in this family may modify the clinical phenotype, as other truncating pathogenic variants typically have a more severe clinical presentation.</p>
            </list-item>
          </list>
          <p>In a given individual, the degree of iron loading and the resultant clinical severity ultimately depends on the combination of genetic and environmental load. For example:</p>
          <list list-type="bullet">
            <list-item>
              <p><xref ref-type="bibr" rid="jh.REF.brakensiek.2009.493">Brakensiek et al [2009]</xref> reported a male with severe JHH who died at age 21 years as a result of severe cardiomyopathy resulting from excessive iron loading. He was homozygous for the common <italic toggle="yes">HJV</italic> pathogenic variant p.Gly320Val<italic toggle="yes">,</italic> compound heterozygous for the <italic toggle="yes">HFE</italic> pathogenic variants p.His63Asp and p.Ser65Cys<italic toggle="yes">,</italic> and homozygous for the <italic toggle="yes">HFE</italic> pathogenic variant IVS2+4T&#x0003e;C, leading the authors to hypothesize that the <italic toggle="yes">HFE</italic> pathogenic variants may have exacerbated the clinical phenotype in this patient.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="jh.REF.gehrke.2005.425">Gehrke et al [2005]</xref> observed that an individual who was homozygous for the <italic toggle="yes">HJV</italic> pathogenic variant p.Gly320Val and heterozygous for the <italic toggle="yes">HFE</italic> pathogenic variant p.Cys282Tyr had a more severe phenotype.</p>
            </list-item>
          </list>
        </sec>
        <sec id="jh.Nomenclature">
          <title>Nomenclature</title>
          <p>Despite use of the locus names HFE2A and HFE2B for the two juvenile hemochromatosis genes, and use of the gene symbol <italic toggle="yes">HFE2</italic> for <italic toggle="yes">HJV</italic> (one of the two juvenile hemochromatosis-related genes), juvenile hemochromatosis is not associated with pathogenic variants in <italic toggle="yes">HFE</italic> &#x02013; mutation of which causes <related-object link-type="booklink" source-id="gene" document-id="hemochromatosis" document-type="chapter"><italic toggle="yes">HFE</italic>-associated hereditary hemochromatosis</related-object>, an adult-onset disorder of iron storage.</p>
          <p>To avoid confusion, all researchers/physicians now prefer to use the locus name HJV and the gene symbol <italic toggle="yes">HJV</italic> for the common juvenile hemochromatosis gene that encodes hemojuvelin.</p>
        </sec>
        <sec id="jh.Prevalence">
          <title>Prevalence</title>
          <p>Juvenile hemochromatosis is rare.</p>
          <p>Affected individuals have been reported worldwide.</p>
          <p>Pathogenic variants in <italic toggle="yes">HJV</italic> represent the majority of worldwide cases of juvenile hemochromatosis. To date, <italic toggle="yes">HJV</italic>-related juvenile hemochromatosis has been reported in individuals of Northern European (including Canadian, American, and Australian) ethnicities; Italian, Greek, Dutch, Albanian, Hungarian, Romanian, Japanese, and Chinese descent; and in the French-Canadian region of Saguenay-Lac-Saint-Jean. No particular ethnic background appears to have a higher frequency; however, a clustering of <italic toggle="yes">HJV</italic> pathogenic variants occurs in Italy and Greece.</p>
          <p>A much smaller number of individuals of Italian, Greek, Arab, and Portuguese descent with <italic toggle="yes">HAMP</italic>-related juvenile hemochromatosis have been reported.</p>
        </sec>
      </sec>
      <sec id="jh.Genetically_Related_Allelic_Disorders">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>To date, no other phenotypes are known to be caused by mutation of <italic toggle="yes">HJV</italic> or <italic toggle="yes">HAMP</italic>.</p>
      </sec>
      <sec id="jh.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Iron overload phenotypes can be primary or secondary.</p>
        <p><bold>Primary iron overload phenotypes</bold> include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="hemochromatosis" document-type="chapter"><italic toggle="yes">HFE</italic>-associated hereditary hemochromatosis</related-object> (adult-onset classic hemochromatosis, type 1 hemochromatosis, HFE1). At the milder end of the spectrum, classic hereditary hemochromatosis is known to be caused by homozygous pathogenic variants in <italic toggle="yes">HFE</italic>, with clinical features typically presenting in the 40s to 50s in contrast to juvenile hemochromatosis, which typically presents before age 30 years. <italic toggle="yes">HFE</italic>-associated hereditary hemochromatosis, considered the classic and most common form, has many features in common with juvenile hemochromatosis, including hypogonadotropic hypogonadism, cardiomyopathy, diabetes mellitus, hepatic cirrhosis, and skin hyperpigmentation; however, the clinical findings of juvenile hemochromatosis are much more severe than those seen in classic hereditary hemochromatosis because of the much higher rate of iron accumulation in the former. In particular, in juvenile hemochromatosis the clinical features of hypogonadotropic hypogonadism and cardiomyopathy are more prominent than those in classic hereditary hemochromatosis [<xref ref-type="bibr" rid="jh.REF.camaschella.2002.242">Camaschella et al 2002</xref>]. Classic hereditary hemochromatosis is caused by increased intestinal iron absorption as a result of a defect in the HFE protein.</p>
            <p>Controversy exists as to the exact penetrance of hereditary hemochromatosis, although it is widely accepted that classic hereditary hemochromatosis, in contrast to juvenile hemochromatosis, is a low-penetrant disorder. In both juvenile hemochromatosis and classic hereditary hemochromatosis, macrophages are iron depleted despite total body iron excess.</p>
            <p>An intermediate iron overload phenotype has been described in individuals with digenic inheritance of heterozygous mutations in <italic toggle="yes">HAMP</italic> and <italic toggle="yes">HFE</italic> or heterozygous mutations in <italic toggle="yes">HJV</italic> and <italic toggle="yes">HFE</italic>. The reports suggest that an explanation for the low penetrance rate in classic hereditary hemochromatosis is the need for genetic modifiers, such as mutations in <italic toggle="yes">HJV</italic> and <italic toggle="yes">HAMP</italic>, in addition to mutations in <italic toggle="yes">HFE</italic> to produce the classic hereditary hemochromatosis disease phenotype. However, because digenic inheritance accounts for a small proportion of individuals with classic <italic toggle="yes">HFE</italic>-associated hereditary hemochromatosis reported to date, other mechanisms are likely to modify penetrance. Further investigation of the importance of <italic toggle="yes">HJV</italic>, <italic toggle="yes">HAMP</italic>, <italic toggle="yes">HFE</italic>, and other iron metabolism-related alleles in the clinical expression of iron overload is warranted [<xref ref-type="bibr" rid="jh.REF.lee.2002.471">Lee et al 2002</xref>, <xref ref-type="bibr" rid="jh.REF.merryweatherclarke.2003.2241">Merryweather-Clarke et al 2003</xref>, <xref ref-type="bibr" rid="jh.REF.lanzara.2004.4317">Lanzara et al 2004</xref>, <xref ref-type="bibr" rid="jh.REF.lee.2004a.4669">Lee et al 2004a</xref>, <xref ref-type="bibr" rid="jh.REF.lee.2004b.224">Lee et al 2004b</xref>, <xref ref-type="bibr" rid="jh.REF.le_gac.2004.674">Le Gac et al 2004</xref>, <xref ref-type="bibr" rid="jh.REF.majore.2004.400">Majore et al 2004</xref>, <xref ref-type="bibr" rid="jh.REF.pietrangelo.2004.2383">Pietrangelo 2004</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="tfr2" document-type="chapter">TFR2 (transferrin receptor 2)-related hemochromatosis</related-object> (type 3 hemochromatosis, HFE3). The iron overload phenotype is variable: in some families, adult onset (similar to that seen in classic <italic toggle="yes">HFE</italic>-associated hereditary hemochromatosis) is observed; in others, the onset occurs before adulthood but later than in juvenile-onset hemochromatosis [<xref ref-type="bibr" rid="jh.REF.camaschella.2000.14">Camaschella et al 2000</xref>, <xref ref-type="bibr" rid="jh.REF.le_gac.2004.674">Le Gac et al 2004</xref>].</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">HFE</italic> (p.Cys282Tyr/p.His63Asp compound heterozygosity) and transferrin receptor 2 (p.Gln317Ter homozygosity). A few individuals clinically diagnosed with juvenile hemochromatosis have not had pathogenic variants in either <italic toggle="yes">HJV</italic> or <italic toggle="yes">HAMP</italic>. In a family with typical clinical findings of JHH in adolescence, no pathogenic variants were identified in either <italic toggle="yes">HJV</italic> or <italic toggle="yes">HAMP</italic>; affected individuals were compound heterozygotes for the <italic toggle="yes">HFE</italic> pathogenic variants p.Cys282Tyr/p.His63Asp and homozygous for the <italic toggle="yes">TFR2</italic> pathogenic variant p.Gln317Ter [<xref ref-type="bibr" rid="jh.REF.pietrangelo.2005.470">Pietrangelo et al 2005</xref>].</p>
          </list-item>
          <list-item>
            <p>Ferroportin (<italic toggle="yes">SLC40A1</italic>)-related iron overload (ferroportin disease; type 4 hemochromatosis, HFE4): Individuals with pathogenic variants in the gene encoding ferroportin also have iron overload; however, unlike individuals with juvenile hemochromatosis and classic <italic toggle="yes">HFE</italic>-associated hereditary hemochromatosis, they show macrophages that are iron laden. Affected individuals have high serum ferritin concentration despite normal/low transferrin-iron saturation at early stages of the disease. Mild anemia can accompany the disease. Anemia may occur early in therapeutic phlebotomy. Ferroportin-related iron overload presents in adulthood and is transmitted in an autosomal dominant manner [<xref ref-type="bibr" rid="jh.REF.montosi.2001.619">Montosi et al 2001</xref>, <xref ref-type="bibr" rid="jh.REF.njajou.2001.213">Njajou et al 2001</xref>].</p>
          </list-item>
          <list-item>
            <p>It is now apparent that different <italic toggle="yes">SLC40A1</italic> pathogenic variants can culminate in different iron overload phenotypes [<xref ref-type="bibr" rid="jh.REF.de_domenico.2006.92">De Domenico et al 2006</xref>]. Ferroportin mutated proteins can be divided into the following two main classes:</p>
            <list list-type="bullet">
              <list-item>
                <p>Proteins that fail to localize to the cell surface and are thus unable to export iron. Affected individuals have typical ferroportin disease with low transferrin saturation and early K&#x000fc;pffer cell iron loading</p>
              </list-item>
              <list-item>
                <p>Proteins that localize to the cell surface but are not responsive to the hepcidin (i.e., the cells show hepcidin resistance). Affected individuals have high transferrin saturation and early hepatocyte iron loading similar to classic <related-object link-type="booklink" source-id="gene" document-id="hemochromatosis" document-type="chapter"><italic toggle="yes">HFE</italic>-associated hereditary hemochromatosis</related-object> [<xref ref-type="bibr" rid="jh.REF.de_domenico.2006.92">De Domenico et al 2006</xref>].</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Neonatal hemochromatosis. Iron overload occurs in utero. This severe, often fatal iron overload syndrome usually presents at birth. Inheritance is unknown; however, autosomal recessive and mitochondrial inheritance have been postulated. No genetic locus has been identified. It has recently been suggested that the fetal liver injury that characterizes neonatal hemochromatosis is the result of maternal alloimmunity. This suggestion is supported by the observation that recurrence rates in families with neonatal hemochromatosis are far greater (&#x02265;90%) than would be predicted by Mendelian inheritance. Furthermore, in women with a history of pregnancy resulting in neonatal hemochromatosis, treatment with high-dose IVIG reduced the risk of having a severely affected child [<xref ref-type="bibr" rid="jh.REF.whitington.2005.544">Whitington &#x00026; Malladi 2005</xref>, <xref ref-type="bibr" rid="jh.REF.whitington.2008.e1615">Whitington &#x00026; Kelly 2008</xref>, <xref ref-type="bibr" rid="jh.REF.rand.2009.566">Rand et al 2009</xref>].</p>
          </list-item>
          <list-item>
            <p>Atransferrinemia. Atransferrinemia is characterized by absent transferrin and, therefore, an inability to deliver iron to the red cell precursors in the bone marrow. This lack of iron for the red cell precursors sets up a powerful erythroid drive with massive intestinal hyperabsorption of iron. Affected individuals are iron overloaded, yet have a microcytic anemia. This condition is an exceedingly rare autosomal recessive disorder, with only a few individuals reported worldwide. Hypotransferrinemia is a milder phenotype that is allelic with atransferrinemia.</p>
          </list-item>
        </list>
        <p><bold>Secondary disorders of iron overload</bold> include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>African iron overload. African iron overload occurs in individuals with a predisposition to iron overload that is exacerbated by excessive intake of dietary iron. It is particularly prevalent among Africans who drink a traditional beer brewed in non-galvanized steel drums. In the past, African iron overload was mainly attributed to dietary excess alone. However, serious iron overload does not develop in all beer drinkers, and not all individuals with iron overload consume excessive amounts of the beer, suggesting that other yet-to-be defined iron-related genes predispose to the condition. A specific pathogenic variant (p.Gln248His) in <italic toggle="yes">SCL40A1</italic>, the gene encoding ferroportin 1, has been associated with tendency to iron overload in Africans and African Americans [<xref ref-type="bibr" rid="jh.REF.beutler.2003.305">Beutler et al 2003</xref>, <xref ref-type="bibr" rid="jh.REF.gordeuk.2003.299">Gordeuk et al 2003</xref>].</p>
          </list-item>
          <list-item>
            <p>Transfusional iron overload. Individuals receiving red blood cell transfusions or any products containing red blood cells on a regular basis develop iron overload as a result of the transfused iron.</p>
          </list-item>
          <list-item>
            <p>Nontransfusional iron overload. Nontransfusional iron overload can occur in conditions in which ongoing erythroid destruction generates an erythroid drive signaling intestinal iron hyperabsorption. For example, iron overload is a feature in <related-object link-type="booklink" source-id="gene" document-id="b-thal" document-type="chapter">beta-thalassemia</related-object> intermedia, for which most affected individuals are not transfused. Other examples include congenital dyserythropoetic anemia and <related-object link-type="booklink" source-id="gene" document-id="sider-anemia" document-type="chapter">sideroblastic anemia</related-object>.</p>
          </list-item>
        </list>
        <p><bold>Disorders of excess ferritin without iron overload</bold> include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hyperferritinemia cataract syndrome (HCS). Individuals with HCS do not have iron overload. They have very high serum ferritin concentration caused by a pathogenic variant in the iron-responsive element in the 5' untranslated region of the gene encoding the ferritin light chain that leads to inappropriate excessive production of ferritin. Transferrin-iron saturation is normal. Individuals with HCS have early-onset bilateral (often congenital) cataracts. Phlebotomy is contraindicated in these individuals [<xref ref-type="bibr" rid="jh.REF.girelli.1995.4050">Girelli et al 1995</xref>, <xref ref-type="bibr" rid="jh.REF.aguilarmartinez.1996.1895">Aguilar-Martinez et al 1996</xref>].</p>
          </list-item>
        </list>
      </sec>
      <sec id="jh.Management">
        <title>Management</title>
        <sec id="jh.Evaluations_Following_Initial_Diagnos">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with juvenile hemochromatosis, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Serum iron status.</bold> Measurements of serum iron concentration, total iron binding capacity, transferrin saturation, and serum ferritin concentration</p>
            </list-item>
            <list-item>
              <p><bold>Pituitary-gonadal axis.</bold> Recording of signs and symptoms of hypogonadotropic hypogonadism and measurement of serum concentration of gonadotropins (i.e., FSH, LH) (pituitary gland) and testosterone (testes) or estradiol (ovaries). In several clinical situations, a dynamic evaluation of the pituitary-gonadal axis is required, consisting mainly of a GnRH (gonadotropic releasing hormone) stimulation test. Pituitary MRI may be considered in some cases.</p>
            </list-item>
            <list-item>
              <p><bold>Affected joints.</bold> Radiographic evaluation</p>
            </list-item>
            <list-item>
              <p><bold>Bone mineral density.</bold> Dual photon absorptiometry of the lumbar spine</p>
            </list-item>
            <list-item>
              <p><bold>Cardiac manifestations.</bold> ECG, transthoracic echocardiogram. In individuals without overt clinical manifestations of cardiac failure or arrhythmias, findings suggestive of left ventricular diastolic dysfunction (reduced left ventricular compliance) often precede evidence of ventricular dilatation and compromised ejection fraction.</p>
            </list-item>
            <list-item>
              <p><bold>Liver function.</bold> Liver histology to determine the extent of liver damage. Documentation of the presence or absence of cirrhosis is of prognostic significance. Current recommendations for <related-object link-type="booklink" source-id="gene" document-id="hemochromatosis" document-type="chapter"><italic toggle="yes">HFE</italic>-associated classic hereditary hemochromatosis</related-object> are that <italic toggle="yes">HFE</italic> p.Cys282Tyr homozygotes with serum ferritin concentration lower than 1000 ng/mL and/or normal liver function enzymes need not be biopsied. Liver biopsy should be considered for individuals with higher serum ferritin concentrations and/or raised liver function enzymes in order to establish prognosis [<xref ref-type="bibr" rid="jh.REF.morrison.2003.627">Morrison et al 2003</xref>]. Because of the rarity of juvenile hemochromatosis, a specific protocol for individuals with juvenile hemochromatosis is not available, but adaptation of the classic <italic toggle="yes">HFE</italic>-associated hereditary hemochromatosis recommendation is a reasonable approach.</p>
            </list-item>
            <list-item>
              <p><bold>Diabetes mellitus.</bold> Screening for diabetes mellitus by overnight fasting plasma glucose measurement and, when indicated, by oral glucose tolerance test.</p>
            </list-item>
          </list>
        </sec>
        <sec id="jh.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Management and treatment recommendations for juvenile hemochromatosis stated here are based on the established <italic toggle="yes">HFE</italic>-associated hemochromatosis recommendations when specific juvenile hemochromatosis information may not exist.</p>
          <p><bold>Treatment of iron overload.</bold> Phlebotomy is the therapy of choice in juvenile hemochromatosis and follows the same principles as the treatment of classic <italic toggle="yes">HFE</italic>-associated hemochromatosis. It is simple, safe, and effective. Affected individuals should be encouraged to follow a regimen of phlebotomy of one unit of blood once or twice weekly [Tavill 2001]. Approximately 200 mg of iron are removed per unit of blood depending on the individual's hematocrit. Because individuals with juvenile hemochromatosis are usually severely iron overloaded, a therapeutic regimen of one to two weekly phlebotomies may take up to two to three years to reduce iron stores to desired levels.</p>
          <p>The hematocrit should be monitored prior to phlebotomy; phlebotomy should be postponed if the hematocrit drops more than 20% of its initial value [Tavill 2001]. Systematic administration of erythropoietin has been successful in maintaining the hematocrit in individuals who failed to mount an adequate bone marrow response to the phlebotomy regimen [<xref ref-type="bibr" rid="jh.REF.de_gobbi.2000.865">De Gobbi et al 2000</xref>].</p>
          <p>Serum ferritin concentration reflects body iron stores and is used to monitor the progress of therapy; it is expected to fall progressively, along with iron mobilization. Measuring serum ferritin concentration every 10-12 phlebotomies is reasonable; however, once serum ferritin concentration is below 100 ng/mL, it should be measured more often, ideally prior to each phlebotomy. Achievement of serum ferritin concentration below 50 ng/mL and restoration of normal transferrin-iron saturation indicates the end point of the intensive phlebotomy treatment.</p>
          <p><bold>Maintenance therapy.</bold> The frequency of phlebotomies is adjusted to maintain normal serum ferritin concentration and transferrin-iron saturation. When iron removal is not urgent, phlebotomies could be spaced further apart according to the responsiveness of the bone marrow to restore adequate hematocrit. Usually four to six phlebotomies annually are sufficient. The individual should permanently continue on this schedule of phlebotomy maintenance therapy.</p>
          <p>Iron chelators such as parenteral deferoxamine (Desferal<sup>&#x000ae;</sup>) are used to treat individuals with secondary iron overload. They are not recommended in the treatment of juvenile hemochromatosis unless the disease is complicated by concomitant anemia or severe cardiac failure. In the latter situation, administration of deferoxamine alone or in combination with deferiprone can reduce mortality by improving left ventricular ejection fraction [<xref ref-type="bibr" rid="jh.REF.kelly.1998.607">Kelly et al 1998</xref>, <xref ref-type="bibr" rid="jh.REF.fabio.2007.362">Fabio et al 2007</xref>].</p>
          <p><bold>Treatment of secondary complications.</bold> Treatment does not essentially differ from the conventional treatment applied in other situations:</p>
          <list list-type="bullet">
            <list-item>
              <p>Hypogonadotropic hypogonadism is generally considered irreversible, despite adequate iron removal. However, reversal of hypogonadism has been observed in some young individuals who have been successfully treated with phlebotomy or iron chelation [<xref ref-type="bibr" rid="jh.REF.angelopoulos.2005.1744">Angelopoulos et al 2005</xref>]. For the majority of individuals with hypogonadism, testosterone or hormone replacement therapy (HRT) is required to improve symptoms and prevent the development of secondary osteopenia or osteoporosis [<xref ref-type="bibr" rid="jh.REF.angelopoulos.2006.150">Angelopoulos et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>Transdermal preparations (i.e., patches) deliver testosterone or estradiol at a controlled rate into the systemic circulation, avoiding first-pass hepatic metabolism; therefore, this approach may be useful for individuals with juvenile hemochromatosis, eliminating the risk of potential liver complications.</p>
            </list-item>
            <list-item>
              <p>Administration of gonadotropins has restored fertility and has led to a twin pregnancy in a woman with juvenile hemochromatosis.</p>
            </list-item>
            <list-item>
              <p>Arthropathy is not modified by treatment. Individuals with juvenile hemochromatosis have to cope with persistent arthralgia presenting at a young age. Painful joints may require treatment with salicylates or nonsteroidal anti-inflammatory drugs (NSAIDS) [<xref ref-type="bibr" rid="jh.REF.vaiopoulos.2003.227">Vaiopoulos et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>Severe cardiac failure is treated with ACE inhibitors, diuretics, cardiac glycosides, and possibly deferoxamine. If left untreated, cardiac disease progresses rapidly and becomes refractory to treatment, leading to death in most cases. Orthotopic heart transplantation has been used on occasion [<xref ref-type="bibr" rid="jh.REF.caines.2005.486">Caines et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Liver steatosis and fibrosis are treated with appropriately early phlebotomy [<xref ref-type="bibr" rid="jh.REF.camaschella.2002.242">Camaschella et al 2002</xref>]; however, it is uncertain whether these features are reversible. Reversibility of liver fibrosis has been reported in individuals treated for <italic toggle="yes">HFE</italic>-associated hemochromatosis [<xref ref-type="bibr" rid="jh.REF.falize.2006.472">Falize et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>Cirrhosis is thought to be irreversible despite iron removal. Individuals with cirrhosis should undergo endoscopic evaluation to document the presence of varices and should be treated with propranolol or nadolol, as indicated. In advanced disease, orthotopic liver transplantation (OLT) could be considered. Of note, individuals with hereditary hemochromatosis undergoing OLT display an overall lower survival than individuals undergoing OLTs for other causes of liver disease. Because most post-transplantation deaths occur in the perioperative period from cardiac disease or infection, it is advisable to remove as much of excess iron stores as possible before OLT even though the effect of excess tissue iron on survival post-OLT is not known [Tavill 2001].</p>
            </list-item>
            <list-item>
              <p>Diabetes mellitus may require insulin administration; successful iron removal may improve its course [<xref ref-type="bibr" rid="jh.REF.angelopoulos.2007.192">Angelopoulos et al 2007</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="jh.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>Individuals with biochemical evidence of iron overload but without evidence of organ dysfunction or failure should be encouraged to undergo regular phlebotomies until excess iron stores are depleted to prevent the development of complications associated with excess iron stores.</p>
          <p>Treatment by phlebotomy in presymptomatic stages can prevent organ damage.</p>
        </sec>
        <sec id="jh.Prevention_of_Secondary_Complications">
          <title>Prevention of Secondary Complications</title>
          <p>HRT prevents the development of osteoporosis.</p>
        </sec>
        <sec id="jh.Surveillance">
          <title>Surveillance</title>
          <p>Whenever hepatic cirrhosis is identified, monitoring for hepatocellular cancer is recommended. Most hepatologists propose twice-yearly screening with abdominal ultrasound examination and serum alpha-fetoprotein concentration [Tavill 2001].</p>
        </sec>
        <sec id="jh.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Avoid the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Alcohol consumption, which has a synergistic effect with iron-induced liver damage in individuals with liver damage</p>
            </list-item>
            <list-item>
              <p>Iron-containing preparations and supplemental vitamin C</p>
            </list-item>
            <list-item>
              <p>Handling or eating uncooked shellfish or marine fish, because of susceptibility to fatal septicemia from the marine bacterium <italic toggle="yes">V vulnificus</italic></p>
            </list-item>
          </list>
        </sec>
        <sec id="jh.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Once a diagnosis of JHH has been made in a family, all at-risk family members (i.e., sibs) should be tested for the pathogenic variants identified in the affected individual. Family members with two <italic toggle="yes">HJV</italic> or <italic toggle="yes">HAMP</italic> pathogenic variants should be followed from early childhood with annual measurement of serum ferritin concentration and transferrin iron saturation to monitor for the development of iron overload.</p>
          <p>If a molecular diagnosis was not made or the genetic status of the sibs of an affected individual is unknown, the sibs should be followed from early childhood with annual measurement of serum ferritin concentration and transferrin iron saturation to monitor for the development of iron overload.</p>
          <p>If juvenile hemochromatosis is detected before evidence of organ damage, either by molecular genetic testing in relatives at-risk or by biochemical testing (i.e., serum ferritin concentration and transferrin-iron saturation), treatment via phlebotomy can reverse or prevent many of the secondary complications resulting from organ damage.</p>
          <p>See <xref ref-type="sec" rid="jh.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="jh.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>All pregnant women with JHH should be under the care of a maternal-fetal medicine specialist, an endocrinologist, and a cardiologist. Preferably women with JHH should be seen by these specialists prior to becoming pregnant.</p>
          <p>Pregnancy in women with untreated JHH is high risk because the increased hemodynamic burden of pregnancy can precipitate cardiac failure in women with an underlying cardiomyopathy. Of note, it is critically important for specialists in endocrinology and infertility to be aware of JHH as a cause of infertility and to evaluate patients for iron overload prior to correcting the underlying hormonal imbalance. In a case report, a young woman who became pregnant following correction of her hypogonadotropic hypogonadism developed fatal cardiogenic shock; she was only identified as having JHH with severe iron overload at the time of presentation of her heart disease [<xref ref-type="bibr" rid="jh.REF.filali.2004.120">Filali et al 2004</xref>].</p>
        </sec>
        <sec id="jh.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="jh.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="jh.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Juvenile hemochromatosis is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="jh.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes and therefore carry one mutated allele.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with juvenile hemochromatosis are obligate heterozygotes (carriers) for a pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier.</p>
          <p>
            <bold>Carrier Detection</bold>
          </p>
          <p>Carrier testing of at-risk family members using molecular genetic techniques is possible if both pathogenic variants have been identified in the family.</p>
        </sec>
        <sec id="jh.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="jh.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
          <p>Use of samples that have been banked should be explicitly approved in a written, revocable consent by each person from whom the sample is obtained. Such consents should detail all known potential biologic, ethical, social, and legal risks and their implications.</p>
        </sec>
        <sec id="jh.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the pathogenic variants have been identified in an affected family member, prenatal diagnosis for a pregnancy at increased risk and preimplantation genetic diagnosis for juvenile hemochromatosis are possible.</p>
          <p>Requests for prenatal testing for conditions which (like juvenile hemochromatosis) do not affect intellect and have treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="jh.Resources">
        <title>Resources</title>
      </sec>
      <sec id="jh.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>
          <bold><italic toggle="yes">HJV</italic> (<italic toggle="yes">HFE2</italic>)</bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">HJV</italic> comprises four exons. The first exon is not translated. Multiple alternate splicing has been observed with five potential transcripts defined. The mRNA is 2.2 kb in size and is highly expressed in liver, skeletal, and cardiac muscle. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="jh" object-id="jh.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> More than 30 different <italic toggle="yes">HJV</italic> pathogenic variants, all in the coding region, have been identified so far in either homozygous or compound heterozygous form. The majority of pathogenic variants appear to be private; however, the <italic toggle="yes">HJV</italic> variant p.Gly320Val is the most prevalent pathogenic variant reported to date, representing more than 50% of all detected pathogenic variants in affected individuals worldwide.</p>
        <p><bold>Normal gene product.</bold> The full-length hemojuvelin protein comprising 426 amino acids is predicted to be approximately 41 kd in size. Bioinformatic analyses revealed that a 35-amino acid hydrophobic signal peptide is at the N-terminal. At the C-terminal, a transmembrane domain and a glycophosphatidyl inositol (GPI) addition signal sequence exist. The GPI anchor is functional in vitro [<xref ref-type="bibr" rid="jh.REF.zhang.2005.33885">Zhang et al 2005</xref>]. At position 98, a tri-amino-acid RGD (Arg-Gly-Asp) domain is thought to be important in cell adhesion. A partial vWF-like domain spans the central portion of the protein (aa 167-253). Several cleavage sites are predicted in hemojuvelin including furin and repulsive guidance molecule (RGM) autocatalytic sites. Overall, the hemojuvelin protein is about 91% homologous to RGM type C in mouse.</p>
        <p>Two isoforms of hemojuvelin have been identified: the full length protein and the disulphide bonded N- and C-terminal chains of hemojuvelin cleaved at the Asp-Pro RGM autocatalytic cleavage site. A soluble form of hemojuvelin is released or secreted and competes with the membrane-bound form of hemojuvelin [<xref ref-type="bibr" rid="jh.REF.lin.2005.2884">Lin et al 2005</xref>]. Iron modulates the release of soluble hemojuvelin [<xref ref-type="bibr" rid="jh.REF.lin.2005.2884">Lin et al 2005</xref>, <xref ref-type="bibr" rid="jh.REF.silvestri.2007.4503">Silvestri et al 2007</xref>, <xref ref-type="bibr" rid="jh.REF.zhang.2007.12547">Zhang et al 2007</xref>], and in primary hepatocytes increasing amounts of soluble hemojuvelin reduced hepcidin mRNA expression [<xref ref-type="bibr" rid="jh.REF.lin.2005.2884">Lin et al 2005</xref>].</p>
        <p>Hemojuvelin is a key upstream regulator of hepcidin expression. Hemojuvelin acts as a coreceptor for bone morphogenetic protein (BMP) signaling in the hepatocyte [<xref ref-type="bibr" rid="jh.REF.babitt.2006.531">Babitt et al 2006</xref>], signaling via BMP receptors and SMADs. Binding of BMPs to their receptor results in the phosphorylation of downstream receptor SMADs including SMAD 1, 5, and 8. In turn these bind to SMAD4, the terminal transcriptional effector critical for mediating hemojuvelin/BMP induction of hepcidin [<xref ref-type="bibr" rid="jh.REF.wang.2005.399">Wang et al 2005</xref>]. Recently, BMP6 has been shown to be the critical regulator of hepcidin signaling through the BMP receptors [<xref ref-type="bibr" rid="jh.REF.andriopoulos.2009.482">Andriopoulos et al 2009</xref>, <xref ref-type="bibr" rid="jh.REF.meynard.2009.478">Meynard et al 2009</xref>].</p>
        <p>Membrane bound hemojuvelin is regulated by the serine protease matriptase-2, with hemojuvelin being a key substrate for the proteolytic activity of matriptase-2. Pathogenic variants in <italic toggle="yes">TMPRSS6</italic>, encoding matriptase-2, underlie iron-refractory iron deficiency anemia (IRIDA), an inherited severe iron deficiency anemia caused by excess hepcidin levels [<xref ref-type="bibr" rid="jh.REF.finberg.2008.569">Finberg et al 2008</xref>]. People with IRIDA have inappropriately elevated levels of the iron regulatory hormone hepcidin, because of a failure of matriptase&#x02011;2 to cleave hemojuvelin resulting in unregulated stimulation of hepcidin expression despite low iron levels [<xref ref-type="bibr" rid="jh.REF.lee.2009.87">Lee 2009</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Individuals with pathogenic variants in hemojuvelin have extremely low levels of hepcidin in urine, suggesting that hemojuvelin normally regulates hepcidin expression [<xref ref-type="bibr" rid="jh.REF.papanikolaou.2004.77">Papanikolaou et al 2004</xref>]. Similarly, hepcidin levels are depressed in hemojuvelin knockout mice [<xref ref-type="bibr" rid="jh.REF.huang.2005.2187">Huang et al 2005</xref>, <xref ref-type="bibr" rid="jh.REF.niederkofler.2005.2180">Niederkofler et al 2005</xref>]. Furthermore, siRNA knockdown of hemojuvelin resulted in decreased hepcidin mRNA expression in primary hepatocytes, underscoring hemojuvelin&#x02019;s critical role in modulating hepcidin. Loss of hemojuvelin function results in decreased BMP signaling in the liver, with associated decreased hepcidin expression.</p>
        <p>
          <bold><italic toggle="yes">HAMP</italic> (<italic toggle="yes">HEPC</italic>)</bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">HAMP</italic> comprises three exons. Exon 3 encodes the active 25-amino acid peptide. The hepcidin mRNA is 0.4 kb in size. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="jh" object-id="jh.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Six different pathogenic variants in <italic toggle="yes">HAMP</italic> causing juvenile hemochromatosis in six independent families have been reported to date [<xref ref-type="bibr" rid="jh.REF.roetto.2003.21">Roetto et al 2003</xref>, <xref ref-type="bibr" rid="jh.REF.delatycki.2004.378">Delatycki et al 2004</xref>, <xref ref-type="bibr" rid="jh.REF.matthes.2004.2181">Matthes et al 2004</xref>, <xref ref-type="bibr" rid="jh.REF.roetto.2004.2407">Roetto et al 2004</xref>, <xref ref-type="bibr" rid="jh.REF.rideau.2007.127">Rideau et al 2007</xref>]. Pathogenic variants have been reported in both coding and non-coding regions of the gene.</p>
        <p><bold>Normal gene product.</bold> The 84-amino acid pre-protein contains an N-terminal signal sequence (24 amino acid) and a penta arginyl proteolysis site, which is used to produce the active C-terminal 25-amino acid peptide. The active peptide comprises eight cysteines forming four disulfide bridges. As hepcidin is a small peptide, it is filtered by the kidney and detectable in the urine. Hepcidin is predominantly expressed in liver, and detected in much lower amounts in heart, brain, lung, and other tissues. Hepcidin functions as a key liver-produced hormone regulating intestinal iron absorption and macrophage iron release. Hepcidin interacts with ferroportin to mediate ferroportin internalization and subsequent degradation. When iron overload occurs, hepcidin is secreted and serves to limit plasma iron concentration by preventing iron uptake in the intestine and preventing iron release from macrophages. In contrast, in the clinical setting of iron deficiency, hepcidin is suppressed to allow intestinal iron absorption.</p>
        <p><bold>Abnormal gene product.</bold> Individuals with mutated hepcidin fail to prevent iron uptake in the intestine, resulting in iron overload. Macrophages are iron-depleted as a result of failure of hepcidin action.</p>
      </sec>
      <sec id="jh.References">
        <title>References</title>
        <sec id="jh.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="jh.Literature_Cited.reflist0">
            <ref id="jh.REF.aguilarmartinez.1996.1895">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aguilar-Martinez</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biron</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masmejean</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeanjean</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schved</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>A novel mutation in the iron responsive element of ferritin L-subunit gene as a cause for hereditary hyperferritinemia-cataract syndrome.</article-title>
                <source>Blood.</source>
                <volume>88</volume>
                <fpage>1895</fpage>
                <pub-id pub-id-type="pmid">8781450</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.andriopoulos.2009.482">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Andriopoulos</surname>
                    <given-names>B</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Corradini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faasse</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grgurevic</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knutson</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrangelo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vukicevic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babitt</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism.</article-title>
                <source>Nat Genet.</source>
                <volume>41</volume>
                <fpage>482</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19252486</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.angelopoulos.2007.192">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Angelopoulos</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papanikolaou</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noutsou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rombopoulos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goula</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolis</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Glucose metabolism, insulin secretion and insulin sensitivity in juvenile hemochromatosis. A case report and review of the literature.</article-title>
                <source>Exp Clin Endocrinol Diabetes</source>
                <volume>115</volume>
                <fpage>192</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17427110</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.angelopoulos.2005.1744">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Angelopoulos</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goula</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimitriou</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolis</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Reversibility of hypogonadotropic hypogonadism in a patient with the juvenile form of hemochromatosis.</article-title>
                <source>Fertil Steril</source>
                <volume>84</volume>
                <fpage>1744</fpage>
                <pub-id pub-id-type="pmid">16359978</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.angelopoulos.2006.150">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Angelopoulos</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goula</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papanikolaou</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolis</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature.</article-title>
                <source>Osteoporos Int</source>
                <volume>17</volume>
                <fpage>150</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15997423</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.babitt.2006.531">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Babitt</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>FW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wrighting</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidis</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samad</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campagna</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneyer</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woolf</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>HY</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.</article-title>
                <source>Nat Genet</source>
                <volume>38</volume>
                <fpage>531</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16604073</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.beutler.2003.305">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beutler</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barton</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Felitti</surname>
                    <given-names>VJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelbart</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waalen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vulpe</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans.</article-title>
                <source>Blood Cells Mol Dis</source>
                <volume>31</volume>
                <fpage>305</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14636643</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.brakensiek.2009.493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brakensiek</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fegbeutel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e4;lzer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Str&#x000fc;ber</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kreipe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stuhrmann</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Juvenile hemochromatosis due to homozygosity for the G320V mutation in the HJV gene with fatal outcome.</article-title>
                <source>Clin Genet.</source>
                <volume>76</volume>
                <fpage>493</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19796184</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.caines.2005.486">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Caines</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kpodonu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massad</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geha</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Cardiac transplantation in patients with iron overload cardiomyopathy.</article-title>
                <source>J Heart Lung Transplant</source>
                <volume>24</volume>
                <fpage>486</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15797753</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.camaschella.1998.227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Camaschella</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Juvenile haemochromatosis.</article-title>
                <source>Baillieres Clin Gastroenterol</source>
                <volume>12</volume>
                <fpage>227</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">9890070</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.camaschella.2000.14">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Camaschella</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roetto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cali</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Gobbi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garozzo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majorano</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Totaro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasparini</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22.</article-title>
                <source>Nat Genet</source>
                <volume>25</volume>
                <fpage>14</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10802645</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.camaschella.2002.242">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Camaschella</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roetto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Gobbi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Juvenile hemochromatosis.</article-title>
                <source>Semin Hematol</source>
                <volume>39</volume>
                <fpage>242</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12382199</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.de_domenico.2006.92">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Domenico</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musci</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Iron overload due to mutations in ferroportin.</article-title>
                <source>Haematologica</source>
                <volume>91</volume>
                <fpage>92</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16434376</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.de_gobbi.2000.865">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Gobbi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquero</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunello</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paccotti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazza</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camaschella</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Juvenile hemochromatosis associated with B-thalassemia treated by phlebotomy and recombinant human erythropoietin.</article-title>
                <source>Haematologica</source>
                <volume>85</volume>
                <fpage>865</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10942934</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.de_gobbi.2002.973">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Gobbi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roetto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piperno</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alberti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papanikolaou</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Politou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lockitch</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fargion</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasparini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cazzola</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camaschella</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Natural history of juvenile haemochromatosis.</article-title>
                <source>Br J Haematol</source>
                <volume>117</volume>
                <fpage>973</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12060140</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.delatycki.2004.378">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Delatycki</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gow</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacFarlane</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radomski</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayden</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samuels</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A homozygous HAMP mutation in a multiply consanguineous family with pseudo-dominant juvenile hemochromatosis.</article-title>
                <source>Clin Genet</source>
                <volume>65</volume>
                <fpage>378</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">15099344</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.fabio.2007.362">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fabio</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minonzio</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delbini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappellini</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by a severe type of juvenile hemochromatosis (JH).</article-title>
                <source>Blood</source>
                <volume>109</volume>
                <fpage>362</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">16960153</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.falize.2006.472">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Falize</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillygomarc'h</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perrin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laine</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guyader</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brissot</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turlin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deugnier</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases.</article-title>
                <source>Hepatology</source>
                <volume>44</volume>
                <fpage>472</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16871557</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.filali.2004.120">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Filali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Jeunne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durand</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grinda</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roetto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daraio</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruneval</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Juvenile hemochromatosis HJV-related revealed by cardiogenic shock.</article-title>
                <source>Blood Cells Mol Dis</source>
                <volume>33</volume>
                <fpage>120</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15315789</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.finberg.2008.569">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Finberg</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heeney</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campagna</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aydinok</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartman</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayo</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samuel</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strouse</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markianos</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).</article-title>
                <source>Nat Genet.</source>
                <volume>40</volume>
                <fpage>569</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">18408718</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.fung.2004.5">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fung</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pakbaz</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fagaly</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vichinsky</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Starr</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ewing</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paulson</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassenzahl</surname>
                    <given-names>WV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harmatz</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The new SQUID biosusceptometer at Oakland: first year of experience.</article-title>
                <source>Neurol Clin Neurophysiol.</source>
                <volume>2004</volume>
                <fpage>5</fpage>
                <pub-id pub-id-type="pmid">16012600</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.gandon.2004.357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gandon</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olivie</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guyader</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aube</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oberti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sebille</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deugnier</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Non-invasive assessment of hepatic iron stores by MRI.</article-title>
                <source>Lancet</source>
                <volume>363</volume>
                <fpage>357</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">15070565</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.gehrke.2005.425">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gehrke</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrangelo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasc&#x000e1;k</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisold</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kulaksiz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrmann</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hebling</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bents</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gugler</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stremmel</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>HJV gene mutations in European patients with juvenile hemochromatosis.</article-title>
                <source>Clin Genet.</source>
                <volume>67</volume>
                <fpage>425</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15811010</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.girelli.1995.4050">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Girelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corrocher</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bisceglia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olivieri</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Franceschi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zelante</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasparini</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation")</article-title>
                <source>Blood</source>
                <volume>86</volume>
                <fpage>4050</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">7492760</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.gordeuk.2003.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gordeuk</surname>
                    <given-names>VR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caleffi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corradini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castro</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onyekwere</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kittles</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pignatti</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montosi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garuti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gangaidzo</surname>
                    <given-names>IT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomo</surname>
                    <given-names>ZA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moyo</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouault</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacPhail</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrangelo</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene.</article-title>
                <source>Blood Cells Mol Dis</source>
                <volume>31</volume>
                <fpage>299</fpage>
                <lpage>304</lpage>
                <pub-id pub-id-type="pmid">14636642</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.huang.2005.2187">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>FW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinkus</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinkus</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>NC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A mouse model of juvenile hemochromatosis.</article-title>
                <source>J Clin Invest</source>
                <volume>115</volume>
                <fpage>2187</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">16075059</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.kelly.1998.607">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhodes</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roland</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schofield</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>TM</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Hereditary juvenile haemochromatosis: a genetically heterogeneous life-threatening iron-storage disease.</article-title>
                <source>QJM</source>
                <volume>91</volume>
                <fpage>607</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">10024915</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.koyama.2005.740">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koyama</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakusawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueno</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katano</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kidokoro</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Three patients with middle-age-onset hemochromatosis caused by novel mutations in the hemojuvelin gene.</article-title>
                <source>J Hepatol</source>
                <volume>43</volume>
                <fpage>740</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">16099526</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.lanzara.2004.4317">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lanzara</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roetto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daraio</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ficarella</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simard</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cazzola</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piperno</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grammatico</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volinia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasparini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camaschella</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis.</article-title>
                <source>Blood</source>
                <volume>103</volume>
                <fpage>4317</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">14982873</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.le_gac.2004.674">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Le Gac</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mons</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacolot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scotet</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferec</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frebourg</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent.</article-title>
                <source>Br J Haematol</source>
                <volume>125</volume>
                <fpage>674</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15147384</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.lee.2009.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Role of matriptase-2 (TMPRSS6) in iron metabolism.</article-title>
                <source>Acta Haematol.</source>
                <volume>122</volume>
                <fpage>87</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">19907145</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.lee.2004a.4669">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beutler</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rao</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barton</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin.</article-title>
                <source>Blood</source>
                <volume>103</volume>
                <fpage>4669</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">14982867</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.lee.2002.471">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelbart</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halloran</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beutler</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Seeking candidate mutations that affect iron homeostasis.</article-title>
                <source>Blood Cells Mol Dis</source>
                <volume>29</volume>
                <fpage>471</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">12547238</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.lee.2004b.224">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barton</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandhagen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beutler</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2004b</year>
                <article-title>Hemojuvelin (HJV) mutations in persons of European, African-American and Asian ancestry with adult onset haemochromatosis.</article-title>
                <source>Br J Haematol</source>
                <volume>127</volume>
                <fpage>224</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15461631</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.lin.2005.2884">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganz</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin.</article-title>
                <source>Blood</source>
                <volume>106</volume>
                <fpage>2884</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15998830</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.majore.2004.400">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Majore</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Binni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pennese</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Santis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crisi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grammatico</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>HAMP gene mutation c.208T&#x0003e;C (p.C70R) identified in an Italian patient with severe hereditary hemochromatosis.</article-title>
                <source>Hum Mutat</source>
                <volume>23</volume>
                <fpage>400</fpage>
                <pub-id pub-id-type="pmid">15024747</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.matthes.2004.2181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matthes</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguilar-Martinez</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pizzi-Bosman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darbellay</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubbia-Brandt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giostra</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beris</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5'UTR of the hepcidin gene.</article-title>
                <source>Blood</source>
                <volume>104</volume>
                <fpage>2181</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15198949</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.merryweatherclarke.2003.2241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Merryweather-Clarke</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cadet</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bomford</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capron</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viprakasit</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McHugh</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pointon</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wimhurst</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livesey</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanphaichitr</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rochette</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.</article-title>
                <source>Hum Mol Genet</source>
                <volume>12</volume>
                <fpage>2241</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12915468</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.meynard.2009.478">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meynard</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kautz</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darnaud</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canonne-Hergaux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coppin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roth</surname>
                    <given-names>MP</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Lack of the bone morphogenetic protein BMP6 induces massive iron overload.</article-title>
                <source>Nat Genet.</source>
                <volume>41</volume>
                <fpage>478</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">19252488</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.montosi.2001.619">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Montosi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donovan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Totaro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garuti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pignatti</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassanelli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trenor</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasparini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrangelo</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene.</article-title>
                <source>J Clin Invest</source>
                <volume>108</volume>
                <fpage>619</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">11518736</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.morrison.2003.627">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandhagen</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phatak</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barton</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krawitt</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Serag</surname>
                    <given-names>HB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gordon</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galan</surname>
                    <given-names>MV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tung</surname>
                    <given-names>BY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ioannou</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowdley</surname>
                    <given-names>KV</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis.</article-title>
                <source>Ann Intern Med</source>
                <volume>138</volume>
                <fpage>627</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">12693884</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.niederkofler.2005.2180">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Niederkofler</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salie</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arber</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload.</article-title>
                <source>J Clin Invest</source>
                <volume>115</volume>
                <fpage>2180</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16075058</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.njajou.2001.213">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Njajou</surname>
                    <given-names>OT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaessen</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joosse</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berghuis</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dongen</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breuning</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snijders</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutten</surname>
                    <given-names>WP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandkuijl</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Duijn</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heutink</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis.</article-title>
                <source>Nat Genet</source>
                <volume>28</volume>
                <fpage>213</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11431687</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.papanikolaou.2004.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Papanikolaou</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samuels</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludwig</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franchini</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dube</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andres</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacFarlane</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakellaropoulos</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Politou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nemeth</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Risler</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaborowska</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babakaiff</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radomski</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pape</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidas</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christakis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brissot</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lockitch</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayden</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>YP</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis.</article-title>
                <source>Nat Genet</source>
                <volume>36</volume>
                <fpage>77</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">14647275</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.pietrangelo.2004.2383">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pietrangelo</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Hereditary hemochromatosis--a new look at an old disease.</article-title>
                <source>N Engl J Med</source>
                <volume>350</volume>
                <fpage>2383</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">15175440</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.pietrangelo.2005.470">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pietrangelo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caleffi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henrion</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corradini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kulaksiz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stremmel</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreone</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garuti</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes.</article-title>
                <source>Gastroenterology</source>
                <volume>128</volume>
                <fpage>470</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15685557</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.rideau.2007.127">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rideau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mangeat</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthes</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trono</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beris</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Molecular mechanism of hepcidin deficiency in a patient with juvenile hemochromatosis.</article-title>
                <source>Haematologica</source>
                <volume>92</volume>
                <fpage>127</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17229647</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.roetto.2004.2407">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roetto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daraio</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porporato</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caruso</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cazzola</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasparini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piperno</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camaschella</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R).</article-title>
                <source>Blood</source>
                <volume>103</volume>
                <fpage>2407</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14630809</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.rand.2009.566">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rand</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karpen</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mack</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malatack</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sokol</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitington</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin.</article-title>
                <source>J Pediatr.</source>
                <volume>155</volume>
                <fpage>566</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">19560784</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.roetto.2003.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roetto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papanikolaou</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Politou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alberti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christakis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loukopoulos</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camaschella</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.</article-title>
                <source>Nat Genet</source>
                <volume>33</volume>
                <fpage>21</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">12469120</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.silvestri.2007.4503">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Silvestri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fazi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerardi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arosio</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camaschella</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis.</article-title>
                <source>Blood</source>
                <volume>109</volume>
                <fpage>4503</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">17264300</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.tavill.2001.1321">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tavill</surname>
                    <given-names>AS</given-names>
                  </name>
                  <collab>American Association for the Study of Liver Diseases</collab>
                </person-group>
                <article-title>American College of Gastroenterology; American Gastroenterological Association. Diagnosis and management of hemochromatosis.</article-title>
                <source>Hepatology.</source>
                <year>2001</year>
                <volume>33</volume>
                <fpage>1321</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11343262</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.vaiopoulos.2003.227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vaiopoulos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papanikolaou</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Politou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jibreel</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakellaropoulos</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loukopoulos</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Arthropathy in juvenile hemochromatosis.</article-title>
                <source>Arthritis Rheum</source>
                <volume>48</volume>
                <fpage>227</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">12528123</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.varkonyi.2000.252">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Varkonyi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaltwasser</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidl</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kollai</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrikovics</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tordai</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>A case of non-HFE juvenile haemochromatosis presenting with adrenocortical insufficiency.</article-title>
                <source>Br J Haematol</source>
                <volume>109</volume>
                <fpage>252</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">10896410</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.wang.2005.399">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zheng</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerfas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooperman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eckhaus</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouault</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mishra</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>CX</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression.</article-title>
                <source>Cell Metab</source>
                <volume>2</volume>
                <fpage>399</fpage>
                <lpage>409</lpage>
                <pub-id pub-id-type="pmid">16330325</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.zhang.2007.12547">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyers</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenstein</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enns</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin.</article-title>
                <source>J Biol Chem</source>
                <volume>282</volume>
                <fpage>12547</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">17331953</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.zhang.2005.33885">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>AP</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Wyman</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjorkman</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enns</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells.</article-title>
                <source>J Biol Chem</source>
                <volume>280</volume>
                <fpage>33885</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">16103117</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.whitington.2008.e1615">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Whitington</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin.</article-title>
                <source>Pediatrics.</source>
                <year>2008</year>
                <volume>121</volume>
                <fpage>e1615</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">18474533</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.whitington.2005.544">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Whitington</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malladi</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Neonatal hemochromatosis: is it an alloimmune disease?</article-title>
                <source>J Pediatr Gastroenterol Nutr.</source>
                <volume>40</volume>
                <fpage>544</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15861012</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="jh.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="jh.Suggested_Reading.reflist0">
            <ref id="jh.REF.brissot.2006.36">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brissot</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Bels</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Current approaches to the management of hemochromatosis.</article-title>
                <source>Hematology Am Soc Hematol Educ Program.</source>
                <year>2006</year>
                <fpage>36</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">17124037</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.franchini.2006.202">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Franchini</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Hereditary iron overload: update on pathophysiology, diagnosis, and treatment.</article-title>
                <source>Am J Hematol.</source>
                <volume>81</volume>
                <fpage>202</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16493621</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.gasparini.2004.341">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gasparini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camaschella</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Hereditary hemochromatosis: is the gene race over?</article-title>
                <source>Eur J Hum Genet.</source>
                <volume>12</volume>
                <fpage>341</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15094740</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.nelson.2005.71">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowdley</surname>
                    <given-names>KV</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Non-HFE hemochromatosis: genetics, pathogenesis, and clinical management.</article-title>
                <source>Curr Gastroenterol Rep.</source>
                <volume>7</volume>
                <fpage>71</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">15701302</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.papanikolaou.2001.744">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Papanikolaou</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Politou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roetto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosio</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakelaropoulos</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camaschella</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loukopoulos</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Linkage to chromosome 1q in Greek families with juvenile hemochromatosis.</article-title>
                <source>Blood Cells Mol Dis.</source>
                <volume>27</volume>
                <fpage>744</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11778658</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.pissia.2004.742">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pissia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polonifi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Politou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lilakos</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakellaropoulos</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papanikolaou</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Prevalence of the G320V mutation of the HJV gene, associated with juvenile hemochromatosis, in Greece.</article-title>
                <source>Haematologica.</source>
                <volume>89</volume>
                <fpage>742</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15194541</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.rivard.2003.585">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rivard</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanzara</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimard</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simard</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ficarella</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simard</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Adamo</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>F&#x000e9;rec</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camaschella</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mura</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roetto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Braekeleer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bechner</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasparini</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Juvenile hemochromatosis locus maps to chromosome 1q in a French Canadian population.</article-title>
                <source>Eur J Hum Genet.</source>
                <volume>11</volume>
                <fpage>585</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12891378</pub-id>
              </element-citation>
            </ref>
            <ref id="jh.REF.roetto.1999.1388">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roetto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Totaro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cazzola</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cicilano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosio</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Ascola</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zelante</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasparini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camaschella</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Juvenile hemochromatosis locus maps to chromosome 1q.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>64</volume>
                <fpage>1388</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">10205270</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="jh.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="jh.Author_Notes">
          <title>Author Notes</title>
          <p>Web: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.xenon-pharma.com"><underline>www.xenon-pharma.com</underline></ext-link></p>
        </sec>
        <sec id="jh.Author_History">
          <title>Author History</title>
          <p>Y Paul Goldberg, MB ChB, PhD, FRCPC (2005-present)Julie MacFarlane, MS, CCGC; Xenon Pharmaceuticals Inc (2005-2011)George Papanikalaou, MD, PhD; National and Kapodistrian University of Athens (2005-2011)</p>
        </sec>
        <sec id="jh.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>11 August 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>17 February 2005 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>12 July 2004 (pg) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
